MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today announced that its WILL cultivation facility in Brampton, Ontario has received its first license to sell cannabis under the Cannabis Act (Canada), which went into effect on October 17, 2018.

The license allows MJardin to supply and sell finished cannabis products to provincial governments throughout Canada and through Canada’s distribution and retail supply chain. The 32,800 square foot facility has a current production capacity of 3,000 kg per year and MJardin has plans to expand WILL’s existing facility and increase total production capacity to over 5,000 kg per year.

In a region known for its harsh penalties for illegal drugs, Thailand is set to become the first nation in Southeast Asia to allow the use of marijuana for medical purposes, writes Richard C. Paddock of New York Times.

Thailand’s military government, which has called elections for the end of February, has backed medical usage, which must be approved by the nation’s monarch, King Maha Vajiralongkorn.

By a vote of 166 to 0, the military-appointed National Legislative Assembly approved legislation this week that would allow the use of cannabis under medical supervision. Thirteen members abstained.

The measure is expected to take effect next year.

At the beginning of a new year, it’s good to develop a “short list” of stocks to follow in the year ahead. These needn’t be stocks you plan on buying. Instead, they can simply be stocks you commit to researching to decide whether you’re going to take a position.

Recently released, the much-anticipated rules on three new classes of cannabis – edibles, concentrates and topicals – impose restrictions on packaging, require strict controls on manufacturing and limit the amount of THC, the psychoactive component in marijuana, allowed in each dose.

A two-month public consultation period is now open before edibles are legalized by October, Health Canada said.

Shirley Toms of Cannabis Compliance Inc., a consulting firm, called the fall timeline doable, noting it’s unlikely to get pushed back as was the legalization of recreational marijuana use, first promised by the federal Liberal by July 1, but delayed until Oct. 17.

This was a record-setting year for the marijuana industry, which put taboo views in the rearview mirror and transformed into a legitimate business model before our eyes.

To our north, Canada put an end to nine decades of recreational marijuana prohibition on Oct. 17. Although it's going to take a few years before production is able to meet domestic demand, this is an industry that's fully capable of $5 billion or more in added annual sales during the early part of the upcoming decade.

The marijuana industry has been one of the most intriguing markets to watch and participate in throughout the year. With so many legislative changes on the way, it seems as though we are only in the beginning stages of massive growth in the market.

This year we saw the first G7 nation legalize marijuana for recreational use which was a major paradigm shift for the industry. Many states in the U.S. also were able to put in new legislation for cannabis laws which has created a new sentiment across the nation. With so much in the works, what are the biggest variables for the next year in cannabis?

A new development in the legislative battle for legal marijuana has recently taken over domestic headlines.

HEXO Corp. (TSX:HEXO) applied to list its shares on the NYSE on Friday, delivering on a promise it made to investors earlier this year. The application is still awaiting approval by the NYSE, but the announcement marks a milestone for the pot stock which prides itself on executing its commitments in a timely fashion.

Licensed cannabis producers are ramping up production to address shortages that have plagued the pot market since legalization in October, but the time required to grow the average marijuana plant means consumers likely have a few more weeks to wait.

Cannabis lives up to its nickname and grows like a weed, but the plant needs as many as 18 weeks to progress from seed to harvest before it even moves on to processing and packaging.

Licensed producer CannTrust walked The Canadian Press through their cultivation and processing facilities to get a close look at the process. Here are the various life stages of the cannabis plant: from seed to plant to processing and packaging.

Israel's parliament has unanimously approved a law to permit exports of medical marijuana, allowing Israel to tap the lucrative global market.

Israel will become the third country, after the Netherlands and Canada, to take its medical cannabis global.

The Israeli medical cannabis company iCAN predicts the global industry will reach $33 billion in the next five years, as stigma fades and demand grows for the few countries certified to export.

The law was approved late Tuesday, sending cannabis company shares rising by about 10 per cent.

The law was stalled for years over fears from security officials that medical marijuana would leak into the black market. To assuage concerns, the law empowers police to supervise licensing.